Marianne P. Allen

Array ( [id] => 4365166 [patent_doc_number] => 06274376 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'ClpL' [patent_app_type] => 1 [patent_app_number] => 8/923511 [patent_app_country] => US [patent_app_date] => 1997-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14985 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274376.pdf [firstpage_image] =>[orig_patent_app_number] => 923511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3999168 [patent_doc_number] => 05986070 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Production of biologically active NGF proteins' [patent_app_type] => 1 [patent_app_number] => 8/918101 [patent_app_country] => US [patent_app_date] => 1997-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 20121 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/986/05986070.pdf [firstpage_image] =>[orig_patent_app_number] => 918101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4403397 [patent_doc_number] => 06270991 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Histidine kinase' [patent_app_type] => 1 [patent_app_number] => 8/916481 [patent_app_country] => US [patent_app_date] => 1997-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15133 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/270/06270991.pdf [firstpage_image] =>[orig_patent_app_number] => 916481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4198673 [patent_doc_number] => 06013630 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Atrial natriuretic factor mutants and ischemic stroke' [patent_app_type] => 1 [patent_app_number] => 8/916043 [patent_app_country] => US [patent_app_date] => 1997-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 21199 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013630.pdf [firstpage_image] =>[orig_patent_app_number] => 916043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4203810 [patent_doc_number] => 06077687 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Flea aminopeptidase nucleic acid molecules and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/906769 [patent_app_country] => US [patent_app_date] => 1997-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 85352 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077687.pdf [firstpage_image] =>[orig_patent_app_number] => 906769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4130209 [patent_doc_number] => 06121035 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Flea aminopeptidase proteins and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/906616 [patent_app_country] => US [patent_app_date] => 1997-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 88404 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121035.pdf [firstpage_image] =>[orig_patent_app_number] => 906616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404312 [patent_doc_number] => 06232096 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Flea serine protease nucleic acid molecules and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/906613 [patent_app_country] => US [patent_app_date] => 1997-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 43592 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 479 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232096.pdf [firstpage_image] =>[orig_patent_app_number] => 906613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4163679 [patent_doc_number] => 06139840 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Methods of eliciting an antibody response using flea protease proteins and homologs thereof' [patent_app_type] => 1 [patent_app_number] => 8/817795 [patent_app_country] => US [patent_app_date] => 1997-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 55899 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/139/06139840.pdf [firstpage_image] =>[orig_patent_app_number] => 817795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6653941 [patent_doc_number] => 20030009015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'BACTERIAL SUPERANTIGEN VACCINES' [patent_app_type] => new [patent_app_number] => 08/882431 [patent_app_country] => US [patent_app_date] => 1997-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17816 [patent_no_of_claims] => 99 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20030009015.pdf [firstpage_image] =>[orig_patent_app_number] => 08882431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4303765 [patent_doc_number] => 06251861 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Treatment of cerebral infarction using cyclic hexapeptides' [patent_app_type] => 1 [patent_app_number] => 8/881878 [patent_app_country] => US [patent_app_date] => 1997-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10763 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251861.pdf [firstpage_image] =>[orig_patent_app_number] => 881878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4137976 [patent_doc_number] => 06060273 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Multicistronic expression units and their use' [patent_app_type] => 1 [patent_app_number] => 8/867352 [patent_app_country] => US [patent_app_date] => 1997-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 13 [patent_no_of_words] => 20533 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060273.pdf [firstpage_image] =>[orig_patent_app_number] => 867352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4107749 [patent_doc_number] => 06022856 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Type-2 neurotensin receptor (NT-R2)' [patent_app_type] => 1 [patent_app_number] => 8/858876 [patent_app_country] => US [patent_app_date] => 1997-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 13943 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022856.pdf [firstpage_image] =>[orig_patent_app_number] => 858876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4158741 [patent_doc_number] => 06103876 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators and gene coding for the inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/855407 [patent_app_country] => US [patent_app_date] => 1997-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 25164 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103876.pdf [firstpage_image] =>[orig_patent_app_number] => 855407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3980378 [patent_doc_number] => 05958710 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Orphan receptor' [patent_app_type] => 1 [patent_app_number] => 8/836620 [patent_app_country] => US [patent_app_date] => 1997-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 29 [patent_no_of_words] => 15431 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958710.pdf [firstpage_image] =>[orig_patent_app_number] => 836620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4218287 [patent_doc_number] => 06040180 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'In vitro generation of differentiated neurons from cultures of mammalian multipotential CNS stem cells' [patent_app_type] => 1 [patent_app_number] => 8/919580 [patent_app_country] => US [patent_app_date] => 1997-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 80 [patent_no_of_words] => 18995 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 323 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040180.pdf [firstpage_image] =>[orig_patent_app_number] => 919580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1239516 [patent_doc_number] => 06686198 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-03 [patent_title] => 'Method of inducing and maintaining neuronal cells' [patent_app_type] => B1 [patent_app_number] => 08/835279 [patent_app_country] => US [patent_app_date] => 1997-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19505 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686198.pdf [firstpage_image] =>[orig_patent_app_number] => 08835279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924433 [patent_doc_number] => 05952223 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Compositions for the diagnosis and treatment of Chediak-Higashi syndrome' [patent_app_type] => 1 [patent_app_number] => 8/822445 [patent_app_country] => US [patent_app_date] => 1997-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 91 [patent_figures_cnt] => 15 [patent_no_of_words] => 55722 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952223.pdf [firstpage_image] =>[orig_patent_app_number] => 822445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4218418 [patent_doc_number] => 06010699 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Method for controlling axial length of the eye' [patent_app_type] => 1 [patent_app_number] => 8/815941 [patent_app_country] => US [patent_app_date] => 1997-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5942 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/010/06010699.pdf [firstpage_image] =>[orig_patent_app_number] => 815941 [rel_patent_id] =>[rel_patent_doc_number] =>)